SEC Form 4 · accession 0001140361-15-036399
WEST CORP · WSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary L West
10% Owner
Period of report
Sep 28, 2015
Accepted (ET)
Sep 30, 2015 · 8:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024657
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 28, 2015 | P | 38,864 | $22.50 | A | 1,917,477 | I | By Gary West CRT2 LLC |
| Common Stock | Sep 28, 2015 | P | 111 | $22.47 | A | 1,917,588 | I | By Gary West CRT2 LLC |
| Common Stock | Sep 28, 2015 | P | 38,863 | $22.50 | A | 1,542,088 | I | By Gary West CRT3 LLC |
| Common Stock | Sep 28, 2015 | P | 110 | $22.47 | A | 1,542,198 | I | By Gary West CRT3 LLC |
| Common StockF1 | Sep 29, 2015 | P | 56,296 | $22.4692 | A | 1,973,884 | I | By Gary West CRT2 LLC |
| Common StockF2 | Sep 29, 2015 | P | 56,296 | $22.4095 | A | 1,598,494 | I | By Gary West CRT3 LLC |
| Common StockF3 | Sep 30, 2015 | P | 12,694 | $22.4318 | A | 2,360,528 | I | By Gary West CRT1 LLC |
| Common StockF4 | Sep 30, 2015 | P | 12,695 | $22.4027 | A | 1,986,579 | I | By Gary West CRT2 LLC |
| Common StockF5 | Sep 30, 2015 | P | 12,695 | $22.3603 | A | 1,611,189 | I | By Gary West CRT3 LLC |
| Common StockF6 | holding | — | — | — | 95,065 | I | By West Investment Holdings, LLC | |
| Common Stock | holding | — | — | — | 1,124,856 | I | By Gary West CRT4 LLC | |
| Common Stock | holding | — | — | — | 806,577 | I | By Gary West CRT5 LLC | |
| Common StockF7 | holding | — | — | — | 93,750 | I | By Gary and Mary West Health Institute | |
| Common StockF8 | holding | — | — | — | 7,889,732 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This price reflects the weighted average purchase price for open-market purchases of shares made by the filing person on September 29, 2015, within a $1.00 range. The actual prices for these transactions range from $22.44 to $22.50, inclusive. The filing person further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- F2This price reflects the weighted average purchase price for open-market purchases of shares made by the filing person on September 29, 2015, within a $1.00 range. The actual prices for these transactions range from $22.40 to $22.44, inclusive. The filing person further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- F3This price reflects the weighted average purchase price for open-market purchases of shares made by the filing person on September 30, 2015, within a $1.00 range. The actual prices for these transactions range from $22.42 to $22.45, inclusive. The filing person further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- F4This price reflects the weighted average purchase price for open-market purchases of shares made by the filing person on September 30, 2015, within a $1.00 range. The actual prices for these transactions range from $22.38 to $22.42, inclusive. The filing person further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- F5This price reflects the weighted average purchase price for open-market purchases of shares made by the filing person on September 30, 2015, within a $1.00 range. The actual prices for these transactions range from $22.30 to $22.38, inclusive. The filing person further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- F6The filing person is a joint indirect owner, with Mary E. West, of West Investment Holdings, LLC. The filing person disclaims any beneficial ownership of any shares held by the West Investment Holdings, LLC except to the extent of his pecuniary interest therein.
- F7The filing person has been appointed sole representative and proxy with respect to the shares held by the Gary and Mary West Health Institute (the "Institute"), a nonprofit organization. The filing person disclaims any beneficial ownership of any shares held by the Institute to the extent of his pecuniary interest therein.
- F8The filing person disclaims beneficial ownership of any shares held by his spouse, Mary E. West, and this report shall not be deemed an admission that the filing person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.